Drug · DIN 02195992
SUPRAX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 7, 2005; first marketed December 31, 1990.
- Drug Identification Number (DIN)
- 02195992
- Company (DIN owner)
- Aventis Pharma Inc.Laval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Oral
- Therapeutic class (ATC)
- Cefixime J01DD08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEFIXIME | 100 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 18, 2001: NOC 2147New Drug Submission (NDS)
- November 29, 1995: NOC 4922New Drug Submission (NDS)
Other DINs named SUPRAX
- DIN 00868965 · Marketed
- DIN 00868981 · Marketed
- DIN 00868973 · Cancelled Post Market
- DIN 02195984 · Cancelled Post Market